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Abstract
The idea that people with severe mental illness should be able toBackground: 
plan in advance for periods of illness as a means of enhancing autonomy has
been long debated and is increasingly being enshrined in codes of practice and
mental health legislation. It has been argued that the ethical imperative for this
is especially pronounced in bipolar (BP), a condition in which sufferers often
experience episodic crises interspersed with periods of wellness. However,
there is a paucity of published research investigating experiences of advance
decision making (ADM) in people with BP or their attitudes towards it.
An online survey of BPUK’s mailing list was conducted. 932 peopleMethods: 
with BP completed the survey (response rate 5.61%). Descriptive statistics and
regression analysis were conducted to compare experience of with attitudes
towards ADM and variables associated with interest in ADM.
A majority indicated a desire to plan care in advance of losingResults: 
capacity (88%) but most had not done so (64%). High numbers of respondents
expressed a wish to request as well as refuse treatment and most wanted to
collaborate with psychiatrists, including on issues around self-binding. The
most frequent motivation to utilise ADM was a desire to be more involved in
mental health decisions. Interest in self-binding was associated with experience
of compulsory treatment and trust in mental health services. Interest in refusals
of all medication was associated with younger age and lack of trust in mental
health services. Interest in ADM in general was associated with younger age
but not educational level, ethnicity or gender.
This study demonstrates an appetite for ADM amongst peopleConclusions: 
with bipolar that is independent of educational status and ethnicity. As states
reform their mental health laws, attention needs to be given to the distinctive
attitudes toward ADM amongst people with bipolar.
1 1 1,2 1,3
1*
1
2
3
*
     Referee Status:
  Invited Referees
 
  
version 2
published
23 Apr 2019
version 1
published
29 Jan 2019
   1 2 3
report
report
report report
, Cardiff University, UKNick Craddock1
, University ofPeter Bartlett
Nottingham, UK
2
, Indian LawSoumitra Pathare
Society, India
3
 29 Jan 2019,  :16 (First published: 4
)https://doi.org/10.12688/wellcomeopenres.14989.1
 23 Apr 2019,  :16 (Latest published: 4
)https://doi.org/10.12688/wellcomeopenres.14989.2
v2
Page 1 of 38
Wellcome Open Research 2019, 4:16 Last updated: 01 MAY 2019
 Keywords
Bipolar, survey, advance decision making, mental capacity, human rights
 Lucy A. Stephenson ( )Corresponding author: Lucy.a.stephenson@kcl.ac.uk
  : Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Software,Author roles: Hindley G
Visualization, Writing – Original Draft Preparation, Writing – Review & Editing;  : Conceptualization, Methodology, ProjectStephenson LA
Administration, Writing – Original Draft Preparation, Writing – Review & Editing;  : Conceptualization, Funding Acquisition,Ruck Keene A
Supervision, Writing – Review & Editing;  : Conceptualization, Funding Acquisition, Supervision, Writing – Review & Editing;  :Rifkin L Gergel T
Conceptualization, Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing;  : Conceptualization, FundingOwen G
Acquisition, Methodology, Project Administration, Supervision, Writing – Review & Editing
 No competing interests were disclosed.Competing interests:
 This study was funded by the Wellcome Trust, grant number 203376.Grant information:
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 © 2019 Hindley G  . This is an open access article distributed under the terms of the  , whichCopyright: et al Creative Commons Attribution Licence
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Hindley G, Stephenson LA, Ruck Keene A   How to cite this article: et al. “Why have I not been told about this?”: a survey of experiences of
and attitudes to advance decision-making amongst people with bipolar [version 2; peer review: 1 approved, 2 approved with
 Wellcome Open Research 2019,  :16 ( )reservations] 4 https://doi.org/10.12688/wellcomeopenres.14989.2
 29 Jan 2019,  :16 ( ) First published: 4 https://doi.org/10.12688/wellcomeopenres.14989.1
Page 2 of 38
Wellcome Open Research 2019, 4:16 Last updated: 01 MAY 2019
Abbreviations
BP – Bipolar
ADM – Advance decision making
AD – Advance decision
MCA – Mental Capacity Act 2005
ADRT – Advance decision to refuse treatment
LPA – Lasting power of attorney
MHA – Mental Health Act 1983
SBD – Self-binding directive
BPUK – Bipolar UK
Introduction
Bipolar (BP) is a common and severe mental illness1. It has a 
worldwide prevalence of approximately 1% and is associated 
with 10–20 years shorter life expectancy2,3. Given its preponder-
ance to present in adolescence and early adulthood and persist 
throughout a person’s life course, it carries a substantial future 
burden of disease4,5. 
A defining feature of BP is its fluctuating course, characterised 
by marked and prolonged changes in mood and energy levels 
interspersed between periods of wellness1. These episodic 
“crises”, which are described as either manic, depressive or 
mixed depending on the predominant polarity of affect, occur 
relatively frequently. Angst et al. reported a median of 1 episode 
every 2.5 and 3 years for BP I and II patients respectively6. 
Episodes can bring an array of destructive sequelae. During a 
manic phase this may include substance misuse, overspending, 
self-harm and psychotic features6. In order to prevent harm 
from such episodes, inpatient psychiatric admission and medica-
tion may be indicated. However, episodes often lead to the loss of 
capacity to make such treatment decisions (hereby referred to 
as capacity) and individuals may uncharacteristically refuse 
treatment and disengage with services when unwell7. 
Decision-making capacity and advance decision-making
Capacity for treatment  is a central (although not universal) 
concept in current, international, medico-legal thinking which 
has applications across medical, psychiatric and social care 
settings. Based upon the principle of self-determination, it 
demands that a person’s decision is respected so long as it is 
made with capacity. If the individual has been judged to lack 
capacity, various mechanisms have been proposed to either make 
a decision that most closely represents the individual’s wishes 
or to act in the person’s best interests8,9. 
For scenarios where an individual can anticipate that capac-
ity will be lost and they have particular views on treatment or 
other issues, advance decision-making (ADM) can be employed. 
ADM is a broad term that encompasses both legally bind-
ing decisions as well as non-legally binding plans and may 
include information about specific decisions, more generic 
information that can inform best interest decisions or the 
designation of a substitute decision maker. ADM may be 
communicated verbally or in writing, resulting in a document that 
is sometimes referred to as an advance directive or advance 
care plan. ADM may be undertaken by the individual alone or in 
collaboration with family, friends and/or professionals10. It can 
also contain information about various aspects of an individual’s 
life such as medical treatment, financial affairs or arrangements 
for work. This study focuses primarily on medical treatment.
Legal provision for advance decision making in England 
and Wales
In England and Wales, the Mental Capacity Act 2005 (MCA) 
details criteria for determining whether a person has capacity 
to decide upon a matter, and the process to follow when this is 
judged to be lacking. This is applicable to any situation in 
which consent is required from an individual. Lack of capacity 
refers to decision making inabilities due to any condition which 
may affect the working of the mind or brain, meaning it is not 
specific to severe mental illness. In situations where capacity 
is lost, the MCA has provisions for ADM in the form of an 
advance decision to refuse treatment (ADRT), an advance state-
ment of wishes and preferences or the appointment of a lasting 
power of attorney (LPA)11. 
There is a second piece of legislation in England and Wales, 
the Mental Health Act 1983 (MHA), that enables compulsory 
treatment for mental disorder. This is of particular relevance to 
people with mental illness such as BP, as they are far more likely 
to be treated under the MHA than the MCA (although if they 
were to be treated for a physical health condition, the MCA 
would still apply). The MHA does not use a capacity-based 
system to determine the need for compulsory treatment, rather 
focusing on the degree of risk of harm to the individual or 
others. Furthermore, in terms of inpatient treatment, it does not 
currently have any statutory provisions for ADM beyond the 
refusal of non-urgent electroconvulsive therapy.
The disparity between provisions for ADM under the MCA and 
the MHA and, by association, people with and without mental 
illness, is two-fold. Firstly, as described above, the MCA has 
various mechanisms for ADM inbuilt while the options are far 
            Amendments from Version 1
Following the comments we have received, we have made the 
following main changes to our manuscript:
1.    We have provided a more detailed and thorough 
description of the limitations of our study. This includes 
the limitations of our sample and therefore generalisability 
of our findings, the survey methodology and the potential 
for misunderstanding among our respondents, and 
the scope of our survey which focused on medical 
decision making. We have also suggested alternative 
methodologies that would address these limitations.
2.    We have provided more explicit definitions for some 
of the terms used in the questionnaire itself.  This 
includes a definition for informal ADM and how the idea 
of self-binding and SBDs have been handled in the 
questionnaire.
3.    Our survey had an implicit focus on medical ADM. We 
have made this explicit in the introduction and the aims. 
See referee reports
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more limited under the MHA. Secondly, if an individual with a 
mental illness attempts to make a legally-binding advance plan 
using the MCA (e.g. ADRT), the MHA can be used to overrule 
it. In the MHA Code of Practice health professionals are advised 
to take the wishes of the person being detained into account. 
However, there is no provision for this within the MHA itself. 
To some people with mental illness and professionals this is 
disempowering and discriminatory.
Autonomy (Self-determination) and ADM
People living with BP (and other mental illnesses) may expe-
rience the loss of a sense of autonomy, or the ability to act 
autonomously at multiple levels. Firstly, they may, in retrospect 
experience periods of illness as inauthentic i.e. not arising from 
their true sense of self. Secondly, during periods of illness an 
individual may experience a loss of self-control, engaging in 
behaviours they would never consider when well. Thirdly, treat-
ment may involve coercive measures. There is pressure from 
the international human rights community to ensure that those 
with disabilities have access to social and legal resources which 
support autonomy, equal to those without disabilities. The United 
Nations Convention of the Rights of Persons with Disabilities 
asserts that those with disabilities (including mental disabili-
ties) should be able to exercise control, equal to that of people 
without disabilities, over all areas of their lives including the 
management of the disability itself12. ADM is seen as one tool by 
which this aspiration could be achieved. Within a European 
context, the Council of Europe (2009) recommends that ‘States 
should promote self-determination for capable adults in the event 
of their future incapacity, by means of continuing powers of 
attorney and advance directives to promote self-determination 
where future incapacity is anticipated’13. It is of note that the 
United Nations Committee on the Rights of Persons with Dis-
abilities does not approve a model which relies on an assessment 
of capacity to determine whether an individual’s choices are 
respected. Instead they advocate for the use of supported 
decision making and understand ADM to be a means to this end14. 
The potential for ADM to support autonomous decision 
making relies on the notion of precedent autonomy15. This is 
the concept that a person’s prior preferences expressed when 
capacitous be given precedence over preferences expressed at a 
later time, when lacking in capacity16. In a mental health setting, 
particular ethical controversies arise as people may wish their 
advance preferences around external coercion to be respected 
during a crisis. For example, they may request early interven-
tion and hospital admission in advance yet during a crisis refuse 
it. A full discussion of the ethical issues is beyond the scope of 
this paper. Suffice to say that some, including the authors of 
this paper, maintain that enabling people with BP to use ADM 
which requests coercion is an autonomy-maximising measure16. 
Advance decision-making and bipolar
Within the medical profession, ADM has been widely dis-
cussed in relation to end-of-life care and life-limiting conditions 
such as dementia. For example, a PubMed search of ADM and 
dementia generates 426 citations, compared to BP’s 14, and 
includes several systematic reviews17–19. However, one of the 
philosophical criticisms of ADM for conditions such as demen-
tia is that the individual has never had personal experience of the 
decisions they are making in advance and they are unlikely to 
regain capacity20.
This is in stark contrast to the experience of someone with BP. 
Not everyone with BP will experience loss of capacity as defined 
by the MCA. However, loss of capacity for treatment decisions 
has been shown to be highly prevalent during manic episodes 
and can occur during a severe depressive episode7. Given its 
fluctuating course, capacity can therefore be said to fluctuate in 
association with affect as depicted in Figure 116. Loss of capac-
ity is also common in other severe mental illnesses, although its 
fluctuating course is probably less predictable than that of BP21.
Theoretically, this suggests that ADM would be well suited to 
BP. The first survey exploring interest in current MCA provision 
amongst people with bipolar in England and Wales strengthens 
this supposition22,23. The majority of respondents were in favour 
of using MCA provision to facilitate advance care planning for 
mental health crises. However use of the provisions for ADM 
under the MCA was low22.
Figure 1. Fluctuating capacity (DMC-T) and remission in mania16.
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If ADM is to be expanded amongst the BP community, it is 
important to refine our understanding of the views of those with 
BP and how existing provision might be tailored to meet the 
needs of those using it. In particular, it is possible that people 
with BP may be practicing ADM without awareness of the MCA. 
In order to make this distinction, we have referred to “informal 
ADM” to mean advance plans that were created outside of the 
MCA framework for advance planning. 
What’s more, as discussed above, those with BP may require 
compulsory inpatient admission and treatment and are therefore 
likely to want ADM provision to plan for this eventuality.
One model of ADM which offers this is a self-binding direc-
tive (SBD) or Ulysses contract24,25. Gergel and Owen propose 
a model tailored for use by people with bipolar according 
to existing legal provision in England and Wales16. An individual 
with bipolar works with a known clinician and family and/or 
friends to create a personalised capacity assessment. The infor-
mation in the document would also inform the assessment 
for involuntary treatment with the aim that a person could be 
contained, according to their advance specifications, in hospi-
tal at an earlier stage in their episode of mania before significant 
damage occurs. Kane proposed an alternative account of this 
model which relies on a personalised notion of ‘risk to self’ rather 
than mental capacity26. However, at the heart of both accounts 
is a willingness to engage with the idea of “self-binding” 
– the concept that the individual wants the contents of their 
plan to be respected even if they no longer agree to it when they 
are unwell. 
In summary, the following has been discussed: BP is a severe 
mental illness in which capacity is likely to be lost during 
episodes of illness, ADM for such episodes is an autonomy pro-
moting tool which has international support and is possible 
within multiple legal jurisdictions including England and Wales, 
the setting for this study. In addition, SBDs may be particularly 
pertinent for those with BP. Given these issues the challenge 
is to work towards a model of ADM which is satisfactory for 
people with BP. With this end in mind, the aims of this survey 
are outlined below.
Aims
This study aimed to address the following objectives, with a 
focus on medical treatment: 
1.    To compare experiences of ADM with preferences for 
ADM amongst people with BP
2.    To describe experiences of using ADM in crisis
3.    To explore attitudes towards ADM including drivers for 
and barriers to ADM
4.    To identify demographic and clinical variables that 
associate with interest in ADMs in general and SBDs in 
particular
Methods
Design
This study was an exploratory internet-based survey of people 
with BP in collaboration with Bipolar UK, the UK’s leading 
bipolar charity.
After reviewing the literature, a pilot questionnaire was designed 
addressing the study aims. This was reviewed by the research 
group which comprised two consultant psychiatrists, a research 
fellow with personal experience of BP, a specialist trainee in 
psychiatry and a specialist barrister in capacity law. The revised 
questionnaire was reviewed by two experienced BPUK employ-
ees before it was piloted on 13 people with BP and carers who 
provided written feedback. Follow-up interviews were conducted 
with a carer and a service-user to discuss the feedback in detail 
and trial possible alterations. The questionnaire was revised a 
second time by the research group. This resulted in the final 
questionnaire covering the following areas: 
1.    Experiences of ADM: use of ADM and experiences of 
utilising ADM during a crisis
2.    Preferences for ADM: interest in ADM, content and 
production of ideal ADM document, attitudes toward 
self-binding
3.    Attitudes towards ADM: drivers, barriers and concerns 
about ADM
4.    History of mental illness: diagnosis, comorbidities, current 
care and history of BP episodes
5.    Demographics: age, gender, ethnicity, education
A variety of single answer closed questions, multiple answer 
closed questions and open questions were utilised. Attitude and 
belief questions employed five-point Likert-type scales which 
have been shown to have adequate reliability and validity in a 
wide range of settings27. Where possible, item-specific response 
scales were chosen rather than agree to disagree scales. This has 
been shown to reduce the degree of participant acquiescence and 
provide higher measurement quality28,29. “I don’t know” options 
were included in the majority of items. This was in response 
to feedback that the subject matter was too foreign for some 
pilots to provide a valid opinion.
The finalised questionnaire was uploaded on to “Bristol Online 
Surveys”30. This is an online survey platform that is utilised by 
over 300 research organisations including 130 UK universities. 
A copy of this survey can be found on Harvard Dataverse31. 
Please note that during the design and implementation of this 
survey, we used the term ‘advance care planning’ specifying if 
statutory or informal kinds were meant.  For a single term, incor-
porating statutory and informal processes, we think “ADM” is 
preferable and use this for the purposes of the paper.
Sample and distribution
The survey was distributed to the BPUK mailing list in October 
2017. At time of distribution, this comprised 20,134 people who 
had registered their email and provided consent to be contacted 
by the charity.
The survey was open for 6 weeks. This was initially adver-
tised by a dedicated email containing the URL to the online 
questionnaire with a description of the project and a request for 
participants. BPUK continued to promote the survey via social 
media, monthly newsletters, a reminder email and direct com-
munication via support groups throughout the 6-week period 
to maximise response rate.
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Figure 2. Flowchart describing survey distribution and generation of study population.
After 6 weeks 3418 people accessed the questionnaire. A 
total of 1131 completed the questionnaire or a parallel carer’s 
questionnaire. This constituted a response rate of 5.61%. 
There were 50 complete questionnaires excluded either due to 
lack of consent, no diagnosis of BP or lack of diagnosis by an 
appropriate professional. A total 149 respondents completed the 
carer’s questionnaire. This left 932 people with BP who met the 
inclusion criteria (Figure 2).
Analysis
Descriptive statistics were calculated using Microsoft Excel 
Professional Plus 2013® and Stata 15.0 ®.
To test for association, we generated the following binary 
outcomes of interest (dependent variables) from the raw data: 
Outcome of interest 1: endorsement of ADM 
This outcome was generated from the item “If you were 
supported by your mental health team to make an advance care 
plan, would you like to make one?” (Supplementary Table 131) 
 Outcome of interest 2: interest in self-binding AND 
willingness to collaborate with a doctor 
This outcome was generated from two items. The first asked 
“Some people think a ‘self-binding statement’ is a good idea. 
This states that the person wants the contents of their advance 
care plan to be respected even if they no longer agree with it when 
they are unwell. Do you think this is a good idea?” The second 
asked “Would you like to collaborate with your psychiatrist or 
GP to produce an advance care plan that they could sign show-
ing they agree with the contents of the plan?” (Supplementary 
Table 231) This was designed as a proxy measure for interest 
in SBDs as these are essential components to the model as 
proposed by Gergel and Owen16.
As there was an unexpectedly high proportion of respondents 
who indicated a preference for refusing all medication, we con-
ducted a post-hoc analysis using a third outcome of interest: 
Outcome of interest 3: preference for refusing all medication
This outcome was generated from the item “What information do 
you think an advance care plan should contain? – a) iii) refusing 
all medication?” 
Demographics, history of mental illness and attitudes towards 
involvement in decision making and trust in mental health 
practitioners were tested for association with the 3 outcomes 
of interest using χ2 tests when all expected values were greater 
than 5 and Fisher’s exact tests when any expected values were 
less than 5 for categorical variables. T-tests and Mann-Whitney U 
tests were applied for normally distributed continuous variables 
and non-normally distributed continuous variables respectively. 
Using a cut-off of 0.05 significance, variables that were found 
to be significantly associated with the outcomes of interest 
were included in univariate logistic regression and multivariate 
regression corrected for potential confounders.
Multiple comparisons
As our objectives are exploratory, we have presented findings 
with an initial threshold for statistical significance of <0.05. We 
subsequently used the Bonferroni-Holm method to correct for 
multiple comparisons. Results which cross this more rigorous 
threshold are indicated by ** and discussed in the text.
Invitation to complete survey distributed by email
to Bipolar UK mailing list (n = 20134)
Survey promoted by weekly social media posts,
monthly newsletters and one reminder email.
Closed after 6 weeks
Potential respondents accessed
questionnaire (n = 3418)
Respondents completed
questionnaire (n = 1131,
response rate = 5.61%)
Study
population:
Service-users
(n = 932)
Carers
(n = 149)
Excluded (n = 50)
•
•
•
•
Did not provide
informed consent
(n = 13)
No BD diagnosis
(n = 28)
Not diagnosed by
appropriate
professional
(n = 9)
Aged < 16 (n = 0)
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and preferences were most common (17% of total sample), while 
ADRTs and LPAs for health and welfare and property and 
finance were less than half as prevalent (6% and 8% respectively). 
A significant proportion of all forms of ADM were communi-
cated verbally (42%; n = 274). A total of 129 (38%) respondents 
reported owning one or more legally binding form of ADM, 
82 (24%) of which had been communicated in writing.
Table 1. Sample demographics and disease characteristics.
Variable n % (n = 932)
Age (years)
Mean = 47.6
SD = 12.6
< 30 85 9
31 – 45 291 31
46 – 60 357 38
> 60
Missing 
148
51
16
6
Gender Male 251 27
Female 665 71
Other 10 1
Ethnicity White British 808 87
Other white 63 7
Black British/
Caribbean/mixed
15 2
Asian/mixed Asian 14 2
Other 21 2
Relationship 
status
Married or cohabiting 501 54
Other 421 45
Education GCSE or lower 166 18
A-levels 161 17
University 598 64
Years since 
diagnosis
Mean = 12.7
SD = 10.6
Less than 5 229 26
5–10 258 28
10 or more
Missing
395
50
42
5
Comorbidity Anxiety 444 48
Post-traumatic stress 
disorder
109 12
Panic disorder 100 11
Emotionally unstable 
PD
99 11
Other 343 37
Level of care CMHT or similar 522 56
Primary care 402 43
Hospital 
admission
Ever 573 61
Never 348 37
Compulsory 
treatment
Ever 305 33
Never 616 66
Missing data
When presenting descriptive statistics, missing values have 
only been reported when greater than 5% total sample. When 
missing values are not reported, proportion of missing values 
is equal to the difference between the summed percentages and 
100. 
When performing logistic regression, missing data was assumed 
to be missing completely at random if missing values were less 
than 5% total sample. In these cases, a complete records 
analysis was conducted.
Two variables, “age” and “years since diagnosis”, had greater 
than 5% missing values. This data was assumed to be missing 
at random and so multiple imputation was applied when using 
these variables. Further details can be found in Supplementary 
Table 331,32. 
Ethics
Ethical approval was provided by the London – Surrey Borders 
Research Ethics Committee and Health Research Authority 
(REC reference number 17/LO/1071).
Informed consent was sought from potential participants prior 
to commencing the survey. Participants were given the opportu-
nity to provide personal email addresses if they wanted to receive 
more information about the project in the future. These were 
uncoupled from the data prior to analysis to prevent loss of 
anonymity. No other identifying information was sought in the 
questionnaire.
Results
Sample demographics and disease characteristics
A total of 932 people with BP completed the survey and met the 
inclusion criteria. The sample had a mean age of 47.6 years and 
was predominantly female (71%), white British (87%) and had 
received a university level education (64%). Mean length of 
time since diagnosis was 12.7 years with 42% of respondents 
having received their diagnosis at least 10 years ago. In total, 
61% had experience of hospitalisation and 56% were receiving 
secondary care or higher. A minority had experience of compul-
sory treatment (33%) (Table 1).
Comparing experience of ADM with preferences for ADM
A total of 337 (36%) people responded positively to the item 
“have you ever written down or told someone about what you 
would like to happen to you or your affairs when you become 
unwell?” Comparatively, 487 (52%) responded definitely yes and 
337 (36%) responded probably yes to the question “If you were 
supported by your mental health team to make an advance 
care plan would you like to make one?”. A smaller majority 
of people thought that a self-binding statement was either defi-
nitely a good idea (n = 356; 38%) or probably a good idea 
(n = 363; 36%).
Types of ADM. The majority of those with experience of 
ADM (66%) described their plans as “informal” (Figure 3). Of 
the MCA provisions for ADM, advance statements of wishes 
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Figure 3. Bar chart comparing actual use with aspiration for various types of ADMs.
Most people stated a preference for non-legally binding ADM. 
In total, 771 (76%) indicated they would make informal ADs 
and 627 (67%) advance statement of wishes and preferences. 
Fewer respondents expressed an interest in making ADRTs 
(35%), LPA health and welfare (43%) or LPA property and finance 
(40%) (Figure 3).
In all types of ADM there was a mismatch between aspiration 
and actuality with higher percentages wanting to engage in ADM 
than had experience of ADM.
Content of Advance Decisions. Respondents indicated that 
“contact details of who to notify” and “who makes decisions 
if you are unable to make decisions for yourself” were the most 
frequent pieces of information contained in their AD (71% and 
68%, respectively). A total of 40% requested specific medi-
cation, 35% refused specific medications and 33% requested 
hospitalisation; 10 respondents (3%) had attempted to refuse all 
medication (Table 2).
A similar pattern is presented when participants were asked 
what information ADs should relate to, with “contact details of 
who to notify” and “who makes decisions if you are unable to 
make decisions for yourself” also being the most frequently 
selected (87% and 89% of the total sample, respectively). An 
equivalent proportion of the total sample wanted to request 
specific medications (69%) as well as refuse specific medica-
tion (68%) and request hospitalisation (68%). A substantial 
number of people indicated a wish to refuse all medication (20%) 
(Table 2).
For all content there was a mismatch between aspiration and 
actuality with respondents indicating a preference for ADs 
that cover a broad range of options. The content aspiration in 
the subsample with experience of ADM was similar to the total 
sample (Table 2).
Support and storage. Respondents most frequently produced 
their ADM with the support of family/friends (42%) or a CPN/
care co-ordinator (37%) (Table 3a); 14% had worked with 
a psychiatrist and 7% with a GP. A minority of ADMs was 
present within psychiatric (36%) or GP (21%) notes. In 
contrast, 70% of participants indicated a preference to collabo-
rate with a psychiatrist and 55% with a GP. Family and friends 
remained the most popular group with 79% preferring their 
support. Most respondents reported a preference for ADMs to 
be kept within psychiatric or GP notes (79% and 83%) as well 
as with family and friends (70%) (Table 3b).
Again, there was an actuality/aspiration mismatch for support 
and storage with higher percentages wanting support and storage 
than had it. The support and storage aspiration in the 
subsample with ADM was similar to the total sample.
Making ADs and their use in crisis
In total, 45% of respondents with ADs were satisfied with the 
contents of their plan, 49% felt more in control because of 
their plan and 51% felt more involved in decisions about their 
healthcare. Despite this, a minority (26%) of respondents had 
experience of their ADs being used in a crisis (Table 4).
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Table 2. Table comparing the actual content of people’s ADs (coloured blue) with the aspirational content 
(coloured green). Aspirational content is divided into two samples (1) the subsample with ADs and (2) the total 
sample. 
Content of ADs What information does 
your AD contain?
What should an AD contain?
People with ADs People with ADs Total sample
n % (n = 337) n % (n = 337) n % (n=932)
Requesting specific medications 134 40 237 70 639 69
Refusing specific medications 118 35 245 73 636 68
Refusing all medications 10 3 78 23 190 20
Requesting ECT 17 5 95 28 241 26
Refusing ECT 104 31 229 70 585 63
Requesting hospitalisation 110 33 220 65 631 68
Where to be treated 108 32 246 73 649 70
Where not to be treated 102 30 212 63 581 62
Description of behaviour or speech 
used when in a crisis
154 46 253 75 642 69
Planning your discharge 33 10 211 63 568 61
Who makes decisions if you are unable 
to make decisions for yourself
230 68 313 90 827 89
Who takes responsibility for your 
finances
159 47 258 77 720 77
Contact details of who to notify 238 71 294 87 806 87
Who not to notify 80 24 182 54 485 52
Table 3. Table comparing (a) who was actually involved in producing the advance decision 
making (ADM) (blue) with aspiration for who should be involved (green) and (b) where ADM 
is actually stored (blue) with aspiration for where it should be stored (green). Aspirations 
are divided into two samples (1) the subsample with ADs and (2) the total sample.
a) Support-giver Who else was involved in 
producing your AD?
Who else should be involved in 
producing an AD?
People with ADs People with ADs Total sample
n % (n = 337) n % (n=337) n % (n=932)
Psychiatrist 48 14 232 69 650 70
GP 24 7 181 54 517 55
Care co-ordinator/CPN 124 37 209 62 505 54
Family/friends 141 42 265 79 736 79
Lawyer 16 5 79 23 218 23
Alone 57 17 18 5 36 4
Other 40 12 78 23 191 20
b) Storage method Where is your AD stored? Where should an AD be stored?
Psychiatric notes 122 36 283 84 737 79
GP notes 70 21 283 84 775 83
At home 111 33 184 55 385 41
Family/friends 116 34 266 79 657 70
Other 43 13 37 11 85 9
I don’t know 38 11 5 1 24 3
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Table 5. Experiences using an advance decision (AD) in a 
crisis.
Question Collapsed Likert 
scales
n % (n=88)
To what extent did 
mental health staff 
respect the contents of 
your AD?
Highly - completely 44 50
Slightly - moderately 31 35
Not at all 12 14
What effect did your AD 
have on your recovery 
from your crisis?
Faster 53 60
No effect 26 32
Slower 2 2
I don’t know 7 8
What effect did 
your AD have on 
your experience of 
treatment?
Better 53 60
No effect 29 33
Worse 6 7
I don’t know 4 5
How helpful was your 
AD in reducing physical 
harm?
Very - extremely 30 34
Slightly - moderately 25 28
Not at all 18 20
Missing 15 17
How helpful was your 
AD in reducing harm to 
relationships?
Very - extremely 39 44
Slightly - moderately 26 30
Not at all 14 16
Missing 9 10
How helpful was 
your AD in reducing 
overspending?
Very - extremely 20 23
Slightly - moderately 35 40
Not at all helpful 21 24
Missing 12 14
How happy are you 
with how your AD has 
been used in general?
Happy 48 55
Neutral or unhappy 39 44
Table 4. Experiences of making an advance decision (AD).
Question/statement Collapsed 
Likert scale
n % (n = 337)
How satisfied are you with 
the contents of your AD?
Satisfied 152 45
Neutral or 
Unsatisfied
135 40
I don’t know 45 13
I feel more in control as a 
result of my AD
Agree 162 48
Neutral or 
disagree
131 39
I don’t know 23 7
I feel more involved in 
decisions about my 
healthcare as a result of 
my AD
Agree 173 51
Neutral or 
disagree
122 36
I don’t know 19 6
Missing 23 7
How many times has your 
AD been used in a crisis?
Never 207 61
Ever 88 26
I don’t know if 
it’s been used
25 7
Of these respondents (n = 88), 50% felt their AD was highly or 
completely respected by mental health staff, 60% felt they had 
recovered faster as a result of their AD and 60% had a better 
experience of health services; 55% were happy with how 
their AD had been used in general. ADs were reported to be 
more effective in reducing harm to relationships (44% very or 
extremely helpful) and physical harm (34%) than reducing 
overspending (23% very or extremely helpful) (Table 5).
Drivers for and barriers to ADM
The most frequently selected reason to make an AD was “I 
would be more involved in decisions about my mental health” 
(84% of respondents). This was followed by “reduce pressure on 
family and friends to make decisions on my behalf”, “improve my 
experience of being treated by mental health services” and “I would 
be more in control of my illness” (74% and 70%, respectively) 
(Table 6).
In terms of barriers, a minority (25%) agreed with the state-
ment “I don’t see the point because Advance Decisions to Refuse 
Treatment can be overruled by the Mental Health Act”, despite 
a majority (71%) indicating that it is very or extremely impor-
tant that ADM should be legally binding. 47% indicated 
that they thought it would be difficult to make an AD while 
only 19% felt it would be too distressing to do so. A significant 
minority agreed with the statement “I don’t understand enough 
about advance care planning” (47%) although most respond-
ents believed that they understood their condition well enough 
to make an AD (72%) (Table 7).
Demographic and clinical variables associated with 
interest in ADM and SBDs, and preference for refusing all 
medication
Of the respondents, 824 (88%) registered an interest in ADM 
(Supplementary Table 131) and 641 (69%) responded positively 
to the self-binding concept and to collaboration with a doctor 
(Supplementary Table 231).
Table 8 shows associations with ADM in general. Of note 
there was no association with gender, ethnicity or education. 
There was a statistically significant association at the 0.05 
threshold between interest in ADM and a younger age, shorter 
time since diagnosis, higher level of care, ever experiencing mania 
and a greater trust in healthcare professionals (Supplementary 
Table 4). After controlling for key demographic variables, 
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younger age, history of manic episodes and trust in healthcare 
professionals remain significantly associated. Only the associa-
tion with younger age remained significant after correction for 
multiple comparisons.
Table 9 shows associations with interest in self-binding with a 
doctor’s involvement. There was no association with age, eth-
nicity, educational level or gender (Supplementary Table 431). 
Interest in self-binding with doctor’s involvement was sig-
nificantly associated with experience of compulsory treatment, 
detention by police and greater trust in healthcare profession-
als. The association with all three variables remained significant 
after controlling for key demographics. Only the association 
with trust in healthcare professionals was significant after 
Bonferroni-Holm correction.
To explore the possibility of a confounding effect between 
compulsory treatment and detention by police, we performed 
further multivariate regression analysis. There was moderate col-
linearity between these variables (r = 0.39, p < 0.00005). When 
controlling for detention by police, the association between 
a history of involuntary detention and interest in self-binding 
Table 6. Attitudes towards drivers for ADM.
Which of the following do you think are 
the most important reasons to make an 
advance decision? n % (n = 932)
I would be more involved in decisions 
about my mental health
787 84
Reduce pressure on family and friends to 
make decisions on my behalf
690 74
Improve my experience of being treated 
by mental health services
655 70
I would be more in control of my illness 643 69
Reduce harm to relationships 557 60
Faster recovery from an episode of mania 
or depression
545 59
Reduce harm to myself during an episode 509 55
Reduce risk of overspending 485 52
Reduce harm to property 261 28
I don’t think there are any significant 
benefits
17 2
Table 7. Attitudes towards potential barriers to ADM.
Collapsed Likert scales Agree Neutral Disagree
n = 932 n (%) n (%) n (%)
I don’t understand enough about ADM 434 (47) 202 (22) 275 (30)
I don’t understand my condition well enough to 
make an AD
104 (11) 134 (14) 673 (72)
I don’t see the point because Advance Decisions to 
Refuse Treatment can be overruled by the Mental 
Health Act
233 (25) 317 (34) 360 (39)
Mental health workers have more than enough time 
to help with ADM
141 (15) 183 (20) 599 (64)
It would be too distressing to think about times when 
I have been unwell during the process of making an 
AD
173 (19) 207 (22) 531 (57)
I don’t think mental health teams would be able to 
access an AD when they need it
338 (36) 303 (33) 275 (30)
I don’t think mental health practitioners would 
respect an AD
313 (34) 318 (34) 284 (30)
Easy Neutral Difficult
How easy do you think it is to make an AD? 198 (21) 298 (32) 433 (47)
Very/extremely Slight/moderately Not at all
How important is it to you that an AD should be 
“legally binding”?
665 (71) 227 (24) 32 (3)
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Table 8. Interest in any ADM: univariate and corrected associations. Univariate regression of age and years since 
diagnosis, and all multivariate regression were conducted using multiple imputation.
Univariate regression
Odds ratio (95% CIs)
Model corrected for age, gender, 
ethnicity, education and 
comorbidity 
 
Odds ratio (95% CIs)
Age* 0.97 (0.95 – 0.98)           p < 0.0005** 0.97 (0.95 – 0.98)             p < 0.0005**
                                               n = 922                                                  n = 896
Years since diagnosis 0.97 (0.96 – 0.99)                p = 0.002 0.99 (0.96 – 1.01)                  p = 0.222
                                               n = 926                                                  n = 896
Level of care GP 1.00 1.00
CMHT or 
higher
1.62 (1.07 – 2.46)                p = 0.024 1.49 (0.96 – 2.31)                  p = 0.074
                                               n = 916                                                  n = 894
Manic episode
0 1.00 1.00
1–4 3.02 (1.13 – 8.12)                p = 0.028 3.34 (1.24 – 9.35)                  p = 0.021
5 or more 3.36 (1.26 – 8.99)                p = 0.016 4.55 (1.62 – 12.81)                p = 0.004
Don’t know 1.85 (0.61 – 5.66)                p = 0.279 2.03 (0.64 – 6.58)                  p = 0.232
                                               n = 913                                                  n = 891
Trust in healthcare 
professionals
Agree 1.00 1.00
Neutral 0.595 (0.35 – 1.02)              p = 0.058 0.64 (0.37 – 1.11)                  p = 0.116
Disagree 0.48 (0.29 – 0.79)                p = 0.004 0.49 (0.29 – 0.83)                  p = 0.008
                                               n = 916                                                  n = 896
**indicates statistical significance after Bonferroni-Holm correction for multiple comparisons.
Table 9. Interest in SBD: univariate and corrected associations. Multivariate regression was conducted using 
multiple imputation.
Univariate regression
Odds ratio (95% CIs)
Model controlling for age, gender, 
ethnicity, education and comorbidity
Odds ratio (95% CIs)
Involuntary detention Never 1.00 1.00
Ever 1.37 (1.01 – 1.86)          p = 0.042 1.55 (1.13 – 2.13)                   p = 0.007   
                                         n = 918                                                   n = 894
Detention by police Never 1.00 1.00
Ever 1.42 (1.02 – 2.00)          p = 0.040 1.45 (1.02 – 2.06)                   p = 0.036   
                                         n = 908                                                   n = 898
Trust in healthcare 
professionals
Agree 1.00 1.00
Neutral 0.57 (0.40 – 0.81)          p = 0.002 0.58 (0.40 – 0.83)                  p = 0.003   
Disagree 0.43 (0.30 – 0.81)     p < 0.0005** 0.43 (0.31 – 0.61)              p < 0.0005    **
                                         n = 921                                                   n = 901
**indicates statistical significance after Bonferroni-Holm correction for multiple comparisons.
Page 12 of 38
Wellcome Open Research 2019, 4:16 Last updated: 01 MAY 2019
with clinician involvement was no longer significant (OR 1.22, 
CIs 0.87-1.70, p = 0.242). When controlling for experience of 
involuntary detention, the association with detention by police 
also became non-significant (OR 1.32, CIs 0.92-1.91, p = 0.134). 
There was no significant interaction between these two variables.
A preference for refusing all medications as part of ADM was 
associated with younger age, fewer years since diagnosis, never 
experiencing hospitalisation, female gender and a lack of trust 
in healthcare professionals (Supplementary Table 531). When 
controlling for confounders, only younger age, female 
gender and lack of trust in healthcare professionals remained 
significant. Younger age and lack of trust in healthcare pro-
fessionals remained significant after correction for multiple 
comparisons (Table 10). There was no association between 
preference for refusing all medication and an interest in ADM 
(χ2 = 0.45, p = 0.504), or interest in self-binding with doctor’s 
involvement (χ2 = 0.91, p = 0.341).
Discussion
This study is the largest survey of attitudes towards ADM 
amongst people with BP, who have traditionally been a hard 
to reach group. It provides an important step forward in under-
standing experiences and attitudes towards ADM in this group. 
Furthermore, it offers insight into how people with BP would 
like ADM provision to be shaped. In a field where the results of 
empirical studies are conflicting but the intervention seemingly 
has high-levels of support among service-users and clinicians 
alike33–35, this understanding is vital in developing accurately 
tailored interventions.
Most strikingly, a large majority of this study’s sample have 
indicated that they would like to plan their care in advance of los-
ing capacity (88%) but most have not done so (64%). Of those 
who have engaged in ADM, a minority have experience of their 
plans being used in crisis. When they are used, respondents 
report generally positive experiences, with 50% feeling that 
their ADs were respected either highly or completely, 60% 
indicating that they recovered faster and 60% experiencing bet-
ter treatment because of their ADs. There is also a notable 
interest in SBDs, with 69% expressing an interest in self-binding 
as well as a willingness to collaborate with doctors.
Limitations
There are several important limitations to this study. This is 
a predominantly white (94%), female (71%), well-educated 
sample (64% university educated) which is not representative 
of the wider population of people with bipolar in the UK 
(88.8% white, 48.9% female,  and 36% university educated)36. 
The use of BPUK mailing list as the sampling frame and a low 
response rate introduce further selection bias. People with a prior 
awareness or interest in ADM are likely to be over-represented. 
It is therefore difficult to generalise these findings and the study 
should be seen as exploratory.
Nonetheless, representative opinions of people with severe men-
tal illness are hard to access and the only comparable study 
performed in the UK reported a sample size of 544 with an unknown 
response rate due to the sampling methodology employed22. 
This study’s larger sample size and transparent methodology 
thus helps take the literature a step forward. The use of other 
Table 10. Preference for advance refusal of all medication: univariate and corrected associations. Univariate 
regression of age and years since diagnosis, and all multivariate regression was conducted using multiple imputation.
Univariate regression
Odds ratio (95% CIs)
Model controlling for age, gender, 
ethnicity, education and comorbidity
Odds ratio (95% CIs)
Age 0.97 (0.95 – 0.98)                    p < 0.0005** 0.97 (0.96 – 0.98)              p < 0.0005**
                                                        n = 924                                                   n = 897
Years since diagnosis 0.97 (0.95 – 0.99)                    p < 0.0005** 0.99 (0.97 – 1.01)                   p = 0.322
                                                        n = 928                                                   n = 897
Hospitalisation Never 1.00 1.00
Ever 0.71 (0.44 – 0.98)                         p = 0.038 0.75 (0.54 – 1.06)                   p = 0.103
                                                        n = 921                                                   n = 891
Gender Male 1.00 1.00
Female 1.75 (1.18 – 2.61)                         p = 0.005 1.58 (1.05 – 2.38)                   p = 0.029
Other 2.56 (0.63 – 10.36)                       p = 0.188 2.70 (0.64 – 11.40)                 p = 0.177
                                                        n = 926                                                   n = 897
Trust in healthcare 
professionals
Agree 1.00 1.00
Neutral 1.27 (0.84 – 1.94)                         p = 0.260 1.22 (0.79 – 1.89)                   p = 0.366
Disagree 2.35 (1.61 – 3.41)                    p < 0.0005** 2.08 (1.41 – 3.08)              p < 0.0005**
                                                        n = 923                                                   n = 897
**indicates statistical significance after correction for multiple comparisons.
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methodologies to sample the attitudes of hard-to-reach groups 
such as respondent-driven sampling may be useful37. While in 
order to understand the generalisability of these findings, a sim-
plified version of the survey should be conducted using a more 
representative sampling technique such as convenience sampling 
through outpatient clinics or systematic sampling through the 
use of a patient research database such as the Clinical Record 
Interactive Search system38.
It is notable that only a minority of our sample have experience 
of involuntary detention (33%). Arguably, this could suggest 
that the majority of this sample have a less severe manifestation 
of BP, are therefore less likely to lose capacity during episodes, 
meaning ADM may not be relevant for these respondents. How-
ever, the majority do have experience of hospitalisation which is 
an important indicator of severity. In addition, during an inpa-
tient admission which coercion, leverage and treatment pressures 
can be present in the absence of legally mandated detention39,40. 
What is more, there was no association between experience of 
compulsory treatment and interest in ADM, suggesting that ADM 
does appeal to people who have not experienced involuntary 
detention.
We utilised a proxy-measure for interest in SBDs by combin-
ing interest in self-binding statements with a willingness to 
collaborate with doctors. This was because we decided that 
attempting to explain SBDs in a survey was likely to generate 
confusion. This means our results cannot be interpreted as a 
direct endorsement for SBDs. We have conducted focus groups 
in which SBDs were discussed as part of a parallel study which 
will help to triangulate these findings.
A quantitative survey was employed to explore and character-
ise a large number of people’s views. The use of closed response 
options, however, limits the depth of opinions and experiences 
reported. What’s more it is possible that some participants 
misunderstood some of the complex concepts contained within 
the questionnaire. Our focus on ADM in relation to medical 
treatment may have added to this potential misunderstanding. 
ADM can relate to financial or work matters and it is possible 
that some of our respondents may have been referring to these 
in some of their responses. Further structured qualitative 
analysis of the free text boxes included in the survey will be 
reported in a future publication, helping to disambiguate this. 
While further research is needed to explore to what extent these 
findings compare to other forms of ADM. 
Consistency with previous studies
Some of our results replicate findings reported by Morriss et al. 
in a survey of the utilisation of the MCA by people with BP22. 
Use of advance statement of wishes and feelings and LPAs 
(property/finance) were somewhat more prevalent among 
our study’s sample (17% and 8%, respectively) compared to 
Morriss et al. (11.4% and 3.9%, respectively). It is possible that 
use of these provisions has increased over time. Use of ADRTs 
and LPAs (health/welfare) was more equivalent, 8% and 6% 
compared to 9.9% and 5.7%, respectively, obtained by Morriss 
et al. In terms of interest, 74.1% “believed making plans about 
their personal welfare if they lost capacity to be very impor-
tant” compared to 88% of our sample that expressed interest 
in ADM22. 
Comparable findings have been reported in wider populations of 
people with severe mental illness rather than just BP. Swanson 
and colleagues found that 4–13% of people with mental illness in 
a large multicentre cohort from the US had psychiatric advance 
directives while 66–77% of this sample wanted to make one41. 
Therapeutic potential of ADM in crisis care and beyond
In this study, of the minority of respondents who did have expe-
rience of using ADM in crisis, 50% indicated their plan was 
highly or completely respected and 60% felt they had recovered 
faster and had a better experience of being treated by men-
tal health services. This builds on Srebnik and Russo’s find-
ing in the U.S. that two thirds of treatment decisions were 
consistent with participants’ psychiatric advance directives42. 
This is preliminary evidence that ADM produced outside of an 
“experimental” setting can be used in crisis with therapeutic 
effect and that they tend to be respected when they are used, 
although it is worth noting that significant proportions of our 
sample did not report these positive experiences. 
Usability and respect have previously been raised as critical issues 
facing the implementation of ADM43. However, as previously 
discussed, in England and Wales the current legal framework 
may act as a barrier to ADM implementation for those with 
mental illness in that there is no MHA provision for formal 
recognition of ADM; Morriss et al. found only 12.5% of 
people with ADRTs had their plans respected when detained 
under the MHA22. 
Half of those with ADs felt more in control because of their 
plan and felt more involved in decisions about their healthcare. 
Wauchope et al. reported similar positive changes in feelings 
of independence, control and motivation in the majority of 
people who were assisted in making ADM44. This suggests there 
are benefits of ADM beyond its role in crisis and that even if 
specific legal provision for ADM for people with mental illness 
is not available in the near future, ADM is still experienced as 
worthwhile by a large proportion of people with mental illness.
Desire for mental health service involvement
The limited involvement of psychiatrists and GPs in the produc-
tion and storage of ADs is striking. Only 21% of ADs were made 
with the help of either a psychiatrist or GP and only 36% were 
present in psychiatric notes. This suggests that, for most people, 
ADM is practised outside of the medical sphere and for many 
it is a “do-it-yourself” exercise with family and friends alone. 
Morriss et al. report similar findings, with only 48% of ADRTs 
having being produced with the help of mental health 
professionals and 48% present in mental health notes22. 
The extent to which mental health services currently engage 
with ADM is likely to be a key factor, although little is known 
about current practice in the UK at NHS Trust level. Bartlett 
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et al. reported that psychiatrists “would discuss more if patients 
requested it”23. Internationally, a degree of ambivalence among 
mental health professionals has also been described. Elbogen 
reported that only 47% of psychiatrists, psychologists and 
social workers believed that ADM “would be helpful to 
consumers”45 and only 28% of Scottish psychiatrists thought 
advance directives were needed in Atkinson and colleagues’ 
survey46. Swanson demonstrates the wide gap between clini-
cians and service-users attitudes, with 78.43% of service users 
believing that “advance instruction will help people…stay well” 
compared to only 43.9% clinicians47. 
Some have suggested that this is the way ADM should be con-
ducted: for ADM to truly enhance autonomy, they should 
be completed without the involvement of mental health 
professionals41,46,48–51. In fact, Henderson et al. reported a prefer-
ence among US veterans for plans to be produced outside of a 
mental health setting and the need for “nonpartisan assistance”52. 
What´s more, Ruchlewska et al. found that “crisis plans” facili-
tated by non-clinicians performed better in a “crisis plan quality 
checklist” than crisis plans completed with clinicians, although 
there was no difference in performance clinically34,53. 
In our sample there was a clear preference for doctors to be 
involved and for plans to be present in medical notes, and inter-
est in ADM was associated with increased trust in mental health 
professionals. Similar attitudes have been reported among serv-
ice users previously as well as other key stakeholders and this 
collaborative approach has been employed by several clinical 
trials of ADM-type interventions34,43,54,55. This would suggest 
that our sample favours a “therapeutic alliance” approach with 
clinical “buy-in” rather than an anti-medical model43. 
These inconsistent findings in the literature may be due to sam-
pling biases, as well as cultural differences between different 
countries. However, it also highlights the breadth of attitudes 
present and the challenges in identifying the “right” way to 
implement such an intervention.
There are several potential consequences to mental health serv-
ices failing to take an active role in ADM. Firstly, our findings 
suggest that ADM is currently ineffective for many people, with 
61% of ADs never having been used in a crisis. This is per-
haps unsurprising given 64% of plans are absent from mental 
health notes. Other UK studies also suggest that only a minority 
of ADM that are created are recorded in written form22,23. This 
is of concern given that in England and Wales at least, multi-
ple agencies may be involved in a crisis: mental health services, 
friends and family, social services and the police. When indi-
viduals from these professional groups were asked about 
ADM, lack of accessibility to electronic and paper docu-
ments across services and localities was seen as a key barrier to 
implementation (Stephenson et al., personal communication).
Secondly, without mental health service involvement, the chance 
of ADM being a source of conflict and disappointment is higher. 
This is most evident in the finding that 20% of this sample 
expressed a wish to refuse all medication. While this may be 
achievable for some, it is possible that treatment would be enforced 
despite their wishes if they were detained under the MHA. 
Service-users refusing all medication has previously been 
described as the biggest concern about ADM among healthcare 
professionals and may contribute to the degree of ambivalence 
described above45,56,57. We have found that preference to refuse 
all medication associates with younger age, which may suggest 
a need for targeted engagement of younger patients to help 
avoid conflict and disappointment later. However, the strong 
association with participants who have less trust in healthcare 
professionals suggests this may be a challenging group to engage.
Thirdly, our sample show high interest in SBDs, particularly 
amongst those with more experience of compulsory treat-
ment. These are types of ADM that will require collaboration 
with mental health services to work as they involve requests, 
rather than refusals, of treatment, often at earlier stages than would 
otherwise happen under the MHA.
Finally, as awareness of ADM increases among people with 
BP and other mental illnesses, the need for clinicians to engage 
at the planning stage may become increasingly evident, as 
clinicians will be expected to respond to questions about ADM 
that have clinical implications58. 
Tailoring advance decision making for bipolar
Medication refusal. The finding that 20% of our sample 
would like to refuse all medication is substantially higher than 
findings in equivalent surveys of people with severe mental ill-
ness, not specifically BP, with figures typically between 0–5%41,59. 
Some of our findings are more consistent with samples that are 
not BP specific. Refusals of ECT, for example, range from 42%59 
to 72%58 while this would be included by 70% of our sample who 
already had ADs and 63% of the entire sample. However, oth-
ers appear to differ more significantly. A total of 96% of Scottish 
advance statements reviewed by Reilly et al. included a spe-
cific medication refusal, while only 35% of ADs in our sample 
included this information and 68% of the total sample would 
include this. Conversely, only 45% of the sample assessed by Reilly 
et al. requested medication, while 68% of our sample would like 
to include this59. 
These differences may be due to sampling differences. How-
ever, this is the first study to explore these issues among a 
BP-specific population. It is therefore possible that there are 
important differences in attitudes between people with different 
diagnoses and that this provides evidence against a “one size fits 
all” approach.
Advance requests for coercive treatment: self-binding direc-
tives. Difference by diagnosis may also be true for the degree of 
interest in SBDs. A study of 104 people with schizophrenia found 
that the majority believed that people should be able to revoke an 
AD even when lacking capacity for treatment decisions47. This 
attitude is in direct opposition to the capacity based model pro-
posed by Gergel and Owen in the bipolar context which stipulates 
that the service-user receives compulsory treatment as outlined 
in their SBD when lacking capacity for treatment decisions in 
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the knowledge that they may resist this treatment when unwell16. 
The majority of bipolar participants in this survey supported the 
idea that contents of their advance care plan should be respected 
even if they no longer agree with it when they are unwell.
Our findings also provide an interesting comparison to some 
of the clinical trials of ADM-type interventions. In our sam-
ple, 68% wanted to be able to request hospitalisation as part of 
an AD. This is in contrast to several of the trials which included 
reduction of hospitalisation rate as an outcome measure, all of 
which failed to demonstrate any effect33,35,57. This helps to illus-
trate a key debate around the appropriate outcome measures 
for ADM: is reduction in hospitalisation the critical test of their 
value? The fact that the five most frequently selected reasons to 
engage in ADM were related to self-determination and rela-
tionships suggest that our sample supports a wide view on the 
appropriate outcome measures for ADM (see Table 6).
Inconsistent attitudes towards legal status
Respondents expressed a preference for non-legally binding 
forms  of ADM which included information about refusing medi-
cation or substitute decision makers over legally binding forms 
that could communicate the same information such as ADRTs 
and LPAs. This is despite 71% of respondents indicating that 
they thought it was either very or extremely important that an AD 
should be “legally binding”. This apparent contradiction may be 
due to a lack of understanding both of the terminology but also 
the legal status of different options available. This is supported 
by the fact that 47% responded that they “did not understand 
ADM well enough”. Low levels of awareness of the MCA has 
previously been reported among people with BP22 while limited 
awareness of ADM in the among people with mental illness 
including dementia has also been identified as a key barrier to 
its implementation60,61. 
Participants’ attitudes in principle may also differ to their atti-
tudes in practice. It is possible that participants believe that it is 
extremely important that ADMs should be legally binding when 
asked in general terms. However, when given the choice of mak-
ing their own plan and invited to consider the practical aspects 
of making a plan, the idea of “binding” themselves and others to 
that plan may seem less appealing. This effect has been described 
in people approaching end-of-life care who may feel 
“intimidated” by something perceived to be legally binding in 
practice62. 
However, this may also reflect a lack of interest in the legally 
binding provisions currently available in England and Wales. 
Much of the preferred content for ADM in our sample, including 
requesting medication and hospitalisation, falls outside of the 
legally binding provisions under the MCA. ADRTs and LPAs 
may therefore seem too limited and restrictive despite their 
legally binding status.
A further possibility is that respondents may prefer the best of 
both worlds; provision with sufficient legal force for their wishes 
to be taken seriously yet with sufficient flexibility which 
accommodates the difficulties of predicting future situations.
Associations with interest in ADM and SBDs
Focus groups exploring psychiatrists’ attitudes towards ADM 
and SBDs (Stephenson et al. personal communication) have elic-
ited assumptions that only a certain “type” of patient will have 
the resources to engage in ADM. Although there may be subtle 
associations that are not apparent due to sample size or a non-
representative sample, it is notable that there was no evidence 
that interest in ADM nor SBD with doctors’ involvement are 
associated with education, ethnicity or gender. This is replicated 
in the survey by Morriss et al., which identified a positive asso-
ciation between knowledge of the MCA and higher educational 
level but not use of the MCA22. These assumptions are likely to 
contribute to the lack of involvement among mental health staff 
who “would discuss more if patients requested it”23. 
In contrast, in their survey of interest in Psychiatric Advance 
Directives among people with severe mental illness, Swanson 
et al. demonstrated a positive association with women, non-
white respondents, lower educational level, recent contact 
with police, high pressure to take medications and low sense 
of personal autonomy. This was interpreted as an attempt by a 
disenfranchised and disillusioned population to regain control41. 
The finding that interest in SBD and ADM are significantly 
associated with increased trust in healthcare professionals may 
be evidence against this hypothesis among our sample. Indeed, 
it is likely that people with less trust in their mental health 
services do not trust their services to enact an AD and there-
fore do not express an interest. Similar attitudes were elicited 
in a qualitative study by Wauchope et al. exploring the process 
of developing ADM for people with severe mental illness, 
observing that participants with negative experiences of mental 
health services were more likely to be suspicious of the process44. 
The variables associated with interest in ADM and SBD 
otherwise differ. This suggests that the group of people inter-
ested in SBD represent a distinct sub-group to those that are 
interested in ADM in general. Most importantly, interest in SBD 
was associated with experience of compulsory treatment. Coer-
cive treatment is central to the SBD model, where the service 
user seeks to have a voice in the kind of coercive treatment that 
is needed for them based on their past experience of illness 
episodes16. This positive association is therefore evidence 
that the concept has been understood and that there is interest 
among the people for whom it is most relevant. Meanwhile, the 
finding that age is inversely associated with interest in 
ADM is in keeping with a generational effect namely that 
younger people are more likely to assume an active role 
in healthcare decisions and less likely to assume medical 
paternalism63. 
Future directions
These results demonstrate sizeable appetite for ADM among a 
large group of people with BP and a desire for input from mental 
health services in creating and implementing ADM for therapeutic 
effect. However, despite this appetite, ADM remains uncommon 
in clinical practice. Translating this enthusiasm into clinical 
practice therefore presents a major challenge.
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Firstly, it is difficult to envisage mental health trusts 
prioritising ADM while it remains an afterthought within men-
tal health legislation in England & Wales. However, this may 
change. The recently published report from the Independent 
Review of the Mental Health Act, to which data from this sur-
vey contributed, has included provision for ADM as one of its 
key recommendations. This presents an exciting opportunity 
to think through and promote ADM within mental health 
with renewed vigour and may lead to new legislation64. 
Legislation alone is unlikely to be successful. Our findings, 
and others, suggest a lack of engagement among mental health 
staff that is likely to stem from resource and training issues, priori-
ties within mental health trusts and assumptions around who may 
be interested in and able to use ADM23,65. 
To enable service users and clinicians to harness the potential of 
ADM top down facilitation and bottom up pressure is required. 
Mental health services need appropriate resources and the 
development of clinically feasible ADM focussed care pathways, 
resources and guidelines. In addition, ongoing advocacy and 
awareness raising from third sector organisations such as BP UK 
can help to raise knowledge of ADM amongst the service user 
community and encourage informed requests for ADM.
Finally, while it is promising that a large proportion of this sam-
ple endorses SBDs, this study’s methodology does not allow 
these attitudes to be explored in depth. There are also sev-
eral key stakeholders whose input and buy-in is essential for 
the model to be implemented successfully. We have therefore 
conducted focus groups with service-users, mental health 
practitioners and lawyers exploring some of the key ethical 
and practical aspects of SBDs (Stephenson Unpublished). Build-
ing on these findings, we will trial one model of clinician/ 
service-user co-produced SBDs for people with BP which will 
commence in 2019.
Conclusions
This study explores the attitudes and experiences of people 
with BP towards ADM in the UK. It has demonstrated that 
ADM is uncommonly practised despite substantial interest. 
The results suggest services users with BP want to use ADM and 
they want collaborative input from mental health services in doing 
so, although the low response rate mean these results should be gen-
eralised with caution. We hope that the results of this study com-
bined with the opportunities provided by the Independent Review 
of the Mental Health Act, will help to translate this interest into 
action and enable people with BP to extend their autonomy 
to situations in which their autonomy is threatened.
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I would provide some additional thoughts flowing from the paper and the comments provided by Dr
Hindley, in hopes that they may assist in conceptualizing forthcoming elements of the project, most
notably the qualitative arm. 
 
My interest in particular is in the comments provided on what Dr Hindley labels as points 2 and 3 in my
comments, notably as regards point 2:
 
'In terms of the specific examples given, although an LPA may be the only   way to designate alegal
substitute decision maker, we should not assume that all service-users should want to operate on a legal
level in this way. The same can be said of ADRTs. This is supported by the fact that 71% of people
indicated a preference for informal Ads which suggests that a large proportion are actively seeking
non-legal routes (although we accept the issues you raise with this definition and discuss these below).'
 
and point 3:
 
'The purpose of differentiating formal from informal in this way was to distinguish between people who had
engaged or wanted to engage  with the MCA and its associated legal framework from peopleknowingly 
who had engaged in ADM outside this legal framework. 
 
'ADM is a complex area where the law interacts with medical practice, ethics and, ultimately, challenging
and distressing moments in people’s lives. Although we agree that any form of ADM has the potential to
be interpreted according to the MCA, we were aware that, for some people, this was not necessarily
something they had considered when drafting their advance plan and, similarly, may not be something
they would like to consider as part of their plan. The reasoning behind this was based on Morriss et al.’s
survey which only addressed the MCA provisions for ADM. As our focus was on a broad definition of
ADM, not limited to MCA.'
 
These raise a forest of questions. 
 
To begin with, what is meant in the comment by ‘legal’ in the response to point 2? If what is meant is that
service users wanted a simple way to give people a real power to make decisions over them without
signing an LPOA (perceived often and with some justification as a technical process, often involving a
lawyer), fair enough – but that is not on offer at the moment. If the point is that the MCA should be
amended to make this possible, that is certainly a debate that can be had.
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 amended to make this possible, that is certainly a debate that can be had.
 
My use of the term ‘legal’ instead was meant to refer to whether the appointments were actually effective,
and unless they are through an LPOA, at the moment they are not. ‘Informal’ schemes do not create
substitute decision-makers; at best they create the purported decision-maker as ‘someone to be
consulted on the matter in question’ [s 4(7)(a) – perhaps surprisingly, a provision we don’t see referred to
much anywhere in the literature]. When the treatment decision gets made, it is still the clinician who
makes it, and he or she must consider whether the treatment is in P’s best interests under s 4. If
notwithstanding the view of the consultee the clinician thinks that it is in P’s best interest, the treatment
should go forward, even if the consultee under 4(7)(a) disagrees, and the doctor exposes himself or
herself to liability if it does not. In that situation, I suspect the person is likely to get treated, whatever the
purported decision-maker identified by P thinks. If what the individual wants is to appoint somebody who
has the actual authority to make the decisions in the event of incapacity so that in this example the
substitute’s refusal holds sway, my original comment stands: the only way to do this at the moment is
through an LPOA.
I would encourage the team to explore some of these issues in the qualitative sessions: what exactly do
people making ‘informal’ appointments of this type think they were doing? The status quo may, after all,
be precisely the result that the individual wanted – formalized involvement of an identified person but not
actually a transfer of decision-making. That is fine, and consistent with the existing Act, but it is not really
appointment of a substitute decision-maker.
That leads to the second part of the comment. I certainly take the point that a minority of people will have
heard of the MCA in their daily lives, although it is much less clear to me why this is a helpful distinction for
purposes of the present paper. To say that the MCA ‘may not be something they would like to consider as
part of their plan’ is much more problematic. With very few exceptions (LPOAs and ADRTs that would
result in the risk to life being the obvious examples), the MCA does not impose formalities requirements
for statements: anything a person says may be relevant to a best interests determination under the MCA.
It is a bit like saying ‘I do’ at the altar – the bride or groom may not want to think about the legal
ramifications at that moment, but they are there nonetheless. I was a part of the team in the Morriss study
cited, and I have to say that I disagree with the characterization that we ‘only addressed the MCA
provisions for ADM’. In our study, almost two thirds of our 650 service user participants had not heard of
the MCA before the study:  it was manifestly not something they had considered when drafting their
advance plans (see Bartlett, Mudigonda, Chopra et al, 270 ). What we did do is look at how those plans
intersected with the provisions of the MCA. In the context of medical treatment, I am struggling to think of
advance planning that would not be MCA relevant; perhaps the authors of the present paper can put me
right on this.
I suggest to the authors that the greater risk is people wishing to ignore or being unaware of the MCA
relevance of their plans, when such relevance does exist. That too is a matter to which we drew attention
(Bartlett, Mudigonda, Chopra et al, 274-5 ). Again, it would be interesting to know from the qualitative
elements of the present project how the people making plans view this set of issues.
All of this moves the discussion a considerable way from the drafting of the present paper, and I am not
sure that further re-drafting will be helpful in addressing the ongoing concerns noted above.  My initial
concerns have been addressed I think as far as they can be given the data.  As for the above comments,
suffice it to say that I look forward to reading the next stage of the research.
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   Soumitra Pathare
Centre for Mental Health Law and Policy, Indian Law Society, Pune, Maharashtra, India
This paper reports the findings of a self-report online survey of attitudes of persons with Bipolar disorder
towards Advance Decision making (ADM). 
I liked the paper and it is an important addition to our understanding of this area. 
I have two concerns which have been raised by two previous reveiwers and an additional concern of my
own.
First, issues of representativeness of the sample, both within the membership of BPUK and the broader
population of persons with Biplolar Disorder who may not be members of BPUK. The former question
(representativeness to membership of BPUK) can possibly be answered by the authors, as BPUK may
have some demographic data on their members. The latter question is probably harder to address.
The issue of representativeness is particularly important as the study had a high level of respondents with
university education and a relatively high level of respondents who had some experience of ADM.
The second issue of concern has also been flagged by one previous reviewer - the clarity of terms and
questions in the questionnaire. For obvious reasons, this cannot now be changed, but it may be useful to
take this into account when planning future studies using online self-report methodology.
I am a little concerned by the authors mixing up concepts as are previously understood in the existing
literature. Advance planning is an expression of a person's will and preference and does not (and should
not) imply that a clinician or family member should be involved (although it maybe a person's choice to
have them involved) and they should consent to this advance planning document.
I am therefore concerned about this statement in the questionnaire:
““Would you like to collaborate with your psychiatrist or GP to produce an advance care plan that they
could sign showing they agree with the contents of the plan?”
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 This should not be regarded as an advance planning document and is closer to a joint crisis plan. This
question does not acknowledge the power dynamics in the patient-doctor relationship (especially in
mental health due the presence of the Mental Health Act) and I am concerned that the authors would
regard this as an advance planning document.
Some minor quibbles:
"Angst et al. reported a median of 0.4 and 0.3 episodes per year for BP I and II patients respectively" - For
ease of reading can this be converted to years eg. 1 episode in 3 years etc.
Can you include a glossary of all the acronyms - it does get confusing at times when reading the paper.
And finally some self-promotion : you may want to read our review of bariers to advance decision making
(see citation below).
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 I have published academic work on this topic previously. I have also been involvedCompeting Interests:
in drafting India's Mental Healthcare Act, 2017 which introduced advance directives into Indian legislation.
Reviewer Expertise: Mental Health Law, Human Rights, Advance planning
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Author Response 04 Apr 2019
, King's College London SE1 1UL, UKGuy Hindley
Thank you for your helpful comments. Please see our responses below:
 
First, issues of representativeness of the sample, both within the membership of BPUK and
the broader population of persons with Bipolar Disorder who may not be members of BPUK.
The former question (representativeness to membership of BPUK) can possibly be
answered by the authors, as BPUK may have some demographic data on their members.
The latter question is probably harder to address.
The issue of representativeness is particularly important as the study had a high level of
respondents with university education and a relatively high level of respondents who had
.some experience of ADM
 
We agree this is an important limitation to our findings and have made several edits to emphasise
this point, including demographic information on the population of people with BP in the UK. Please
see our replies to Professor Craddock’s report above. 
 
2.The second issue of concern has also been flagged by one previous reviewer - the clarity of
terms and questions in the questionnaire. For obvious reasons, this cannot now be changed, but it
may be useful to take this into account when planning future studies using online self-report
methodology.
 
We agree that this study would have benefited with more clarity at the design stage. We will
certainly learn from this for future studies. Please also see our reply to Peter Bartlett’s report
above. 
 
3.I am a little concerned by the authors mixing up concepts as are previously understood in the
existing literature. Advance planning is an expression of a person's will and preference and does
not (and should not) imply that a clinician or family member should be involved (although it maybe
a person's choice to have them involved) and they should consent to this advance planning
document.
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 a person's choice to have them involved) and they should consent to this advance planning
document.
I am therefore concerned about this statement in the questionnaire:
““Would you like to collaborate with your psychiatrist or GP to produce an advance care plan that
they could sign showing they agree with the contents of the plan?”
This should not be regarded as an advance planning document and is closer to a joint crisis plan.
This question does not acknowledge the power dynamics in the patient-doctor relationship
(especially in mental health due the presence of the Mental Health Act) and I am concerned that
the authors would regard this as an advance planning document
 
We agree that this statement is very much in line with the Joint Crisis Plan model. However, we
disagree that this means it is therefore no longer an advance planning document, or alternately an
advance decision. Although definitions may differ, our understanding of the term advance decision
is a decision that is made in advance of someone losing the ability to make that decision for
themselves. It therefore makes no judgement on how or with whom this decision is made so long
as the individual is involved in that decision-making process. 
 
If we utilise this definition, there can therefore be several different approaches to practicing ADM.
Nicaise et al. provide an interesting analysis of the conceptual frameworks behind different
psychiatric advance directives breaking it down into “user’s autonomy”, “therapeutic alliance” and
“integration of care-partnership”. According to this approach, your definition would fall firmly under
the “user’s autonomy” domain, while Joint Crisis Plans, and the sort of intervention hinted at in the
question above would lean more to the “Therapeutic Alliance” domain. What’s more, we do make
reference to this alternative model for ADMs in the text as you can see below:
 
“Some have suggested that this is the way ADM should be conducted: for ADM to truly enhance
autonomy, they should be completed without the involvement of mental health professionals” (P14)
 
This is not to say that the power dynamics within the doctor-patient relationship are not a key
consideration to this kind of ADM, and perhaps an area that we have not explored sufficiently
within our study. Nonetheless, we feel this is, at present, outside the scope of our paper and we
remain of the opinion that the model proposed above is consistent with the broader definition for
ADM that we and others have used.  
 
4."Angst et al. reported a median of 0.4 and 0.3 episodes per year for BP I and II patients
respectively" - For ease of reading can this be converted to years eg. 1 episode in 3 years etc.
 
This has been changed accordingly. 
 
5.Can you include a glossary of all the acronyms - it does get confusing at times when reading the
paper.
 
We have removed several of the acronyms and also provided a glossary of the remaining
acronyms. 
 
6.And finally some self-promotion: you may want to read our review of bariers to advance decision
making (see citation below).
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Thank you for pointing us in the direction of your informative review. We hope our findings help
elaborate further on many of the themes you have discussed. It was particularly helpful to read
your discussion on revocability, enforceability and prior knowledge. We have expanded slightly our
discussion on the latter to reflect this and referenced your review accordingly:
 
“Low levels of awareness of the MCA has previously been reported among people with BP while
limited awareness of ADM among people with mental illness including dementia has also been
identified as a key barrier to its implementation ”
References:
Nicaise P, Lorant V, Dubois V. Psychiatric Advance Directives as a complex and multistage
intervention: a realist systematic review.  . 2013;21(1):1-14.Health Soc Care Community
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   Peter Bartlett
School of Law and Institute of Mental Health, University of Nottingham, Nottingham, UK
This article reports the results of an online survey of the attitudes of people with bipolar disorder (n=932)
to various forms of advance decision-making in anticipation of a loss of mental capacity. The article is
quantitative only: there is no qualitative analysis.
 
There is much in this article to like. It would appear to be a robust and statistically astute survey, drawn
from the contact list of Bipolar UK. Statistical techniques appear appropriate, and, in methodological
terms, the findings seem convincing.
 
I am happy enough with the sample size, but a bit more discussion might be appropriate as to its
representativeness. I understand that this cannot be according to the classic statistical rules – it is not
‘random’ in that sense – but it would be helpful to know whether the demographics of the sample broadly
match the demographics of the broader population of people with bipolar. I also note that fewer than 1/3
of the people who accessed the questionnaire finished it. As it stands, the response rate is only 5.6%,
less almost 1/6 of responses that were excluded [p5]. Some indication of how typical this sample is of
people with bipolar would be helpful.
 
I think the article would be significantly improved if some of the concepts and categories were explained
more carefully, and/or the apparent incoherences discussed more carefully.  On page 7, for example, we
are told that 68% of respondents wanted to state who should make decisions for them in the event that
they lost capacity, but only 40-43% would make an LPA, without any acknowledgement that the only legal
way to do the former is to do the latter – that is what an LPA is, and without it, any view as to who should
make decisions for you has no effect - it is still (for medical decisions) the treating physician. There is
similarly nothing to suggest that the people who wished to refuse specific medications understood that the
way you do that is through an ADRT (the numbers are similar for each - if they were the same people, that
should be explained, but I would be surprised). I suspect what is going on here is that the respondents
4
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 should be explained, but I would be surprised). I suspect what is going on here is that the respondents
have limited and sometimes incorrect knowledge of the legal provisions. That is fair enough – normal
people do not sleep with copies of the MCA under their pillows, and cannot readily parrot out its terms –
but if in fact they do not really understand the provisions, and may misunderstand them in different ways,
it raises questions as to how we interpret their responses. 
 
The paper similarly speaks of ‘informal’ plans, as distinct (it would seem) from ADRTs and statements of
wishes. It is not at all clear what this means. It is possible that some respondents read it as a distinction
between oral and written statements, since the questionnaire refers to ADRTs and statements of wishes
as ‘legal documents’. In this the questionnaire is deficient, since there is no requirement under the MCA
that statements of wishes nor (with exceptions not relevant here) that ADRTs be in any particular form: in
both cases quite informal statements, including oral statements, are meant to have legal effect. (I think
there is a sensible argument to the effect that the MCA should not have taken that approach, but that is an
issue for another time: that is the approach it takes.) At other times, though, the questionnaire seems to
view advance care plans or crisis plans (presumably whether oral or in writing?) as ‘informal’, in
juxtaposition to ADRTs and statements of wishes. Again, it is not at all clear what distinction is being
drawn here, as wishes or treatment refusals contained in care plans or crisis plans are manifestly
statements of wishes or ADRTs under the MCA. This lack of clarity again makes analysis of the results
difficult: what did the people think they were agreeing to?
 
Page 4 of the draft contains an explanation of what is meant by ‘self-binding directive’, a concept that is
discussed at some length in the paper. There is a difficulty that the detail of this definition is not reflected
in the only question about SBDs in the questionnaire, which refers only to ‘the person want[ing] the
contents of their advance care plan to be respected even if they no longer agree with it when they are
unwell.’  Again, I am not sure that one can slide between the two articulations in quite the way that the
paper does.
 
There is an ambiguity running throughout the questionnaire as to whether it is about treatment for mental
health conditions or advance decision-making much more broadly. The questionnaire tends to phrase
advance decision-making in the context of involvement by the care team and medical professionals,
suggesting the former, while there are references in addition to much broader planning, albeit often
placed in the context of a care plan (which is generally understood as a relatively medical mechanism).
These distinctions are not always teased out as carefully as they might have been. Thus one might well
imagine an affected person P wanting to discuss his or her medical treatment choices with medical and
care professionals; it is much less obvious that he or she would, if running a business, want to discuss
with medical and care professionals how the business should be run in the event of incapacity. The paper
does seem to elide these differences at times, and I am afraid I did not find this convincing, and when
respondents are discussing who they would seek advice from, it is not obvious which sort of decision they
had in mind.
 
These issues I think really are problematic, and it is difficult to see how they can be remedied since they
flow from the questionnaire itself. The ambiguities do make it somewhat difficult to see how the analysis of
the results should be understood, however.
 
I have a number of lesser criticisms that the authors might wish to consider.
 
In the discussion of the MCA and MHA, it would be worth noting that the MHA covers only treatment for
mental disorder: If a person with bipolar has a somatic health disorder, the MCA applies.
 
The discussion of ADs and their use in crisis situations is interesting but begs the question of the 50% of
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 The discussion of ADs and their use in crisis situations is interesting but begs the question of the 50% of
respondents who did not feel that their plan was respected in the crisis, the 40% that did not think they
recovered faster, the 40% that did not report improved experience of health services, the 45% that were
not happy with how their plan had been used in the crisis, the 56% that did not find that the plans were
very or extremely helpful in reducing harm to relationships, the 66% that did not report a reduction in
physical harm, and the 77% that did not find them very or extremely helpful in reducing overspending. It
does feel rather that we are being told half a story here!
 
The fact that after the statistical beeps and whistles get applied, the only correlation with support of SBDs
is shown to be trust in medics is in a sense profoundly unsurprising – although still worth saying. It does
return to the question of what is meant by an SBD, and medical contextualisation. Do we know whether
they were thinking of medical SBDs here (as would be my guess) as distinct from SBDs, say, as to how a
business will be run?
 
Finally, I think that for a paper of this size, there is too much of a deluge of acronyms – BP, SMI, DMC-T,
ADM, ADRT, EPA, UNCRPD (used only once in the body of the text), MHA, MCA, AS, SBD, BPUK. Are
they all really necessary? Only about half will be known to people who work in the field; even for them the
paper will therefore be hard going. For neophytes, this is likely to be a serious barrier.
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Thank you for your detailed and insightful comments. Please see below for responses to the issues
you have raised:
 
I am happy enough with the sample size, but a bit more discussion might be appropriate as
to its representativeness. I understand that this cannot be according to the classic statistical
rules – it is not ‘random’ in that sense – but it would be helpful to know whether the
demographics of the sample broadly match the demographics of the broader population of
people with bipolar. I also note that fewer than 1/3 of the people who accessed the
questionnaire finished it. As it stands, the response rate is only 5.6%, less almost 1/6 of
responses that were excluded [p5]. Some indication of how typical this sample is of people
with bipolar would be helpful.
 
This is certainly an important limitation that is discussed in depth in Professor Nick Crawford’s
report above. As mentioned above, we are unfortunately unable to compare the demographics of
our sample directly to the BPUK’s mailing list as they do not store this information. Nor are we able
to compare the demographics of people who started the survey to people who finished the survey,
which would also provide some insight into the response rate, as the demographics was at the end
of the survey. Nonetheless your suggestion to compare our demographics to those of the wider
population of people with bipolar is helpful. We have therefore added the following to our
discussion:
 
“This is a predominantly white (94%), female (71%), well-educated sample (64% university
educated) which is not representative of the wider population of people with bipolar in the UK
(88.8% white, 48.9% female  and 36% university educated) .”
 
2. I think the article would be significantly improved if some of the concepts and categories were
explained more carefully, and/or the apparent incoherences discussed more carefully.  On page 7,
for example, we are told that 68% of respondents wanted to state who should make decisions for
them in the event that they lost capacity, but only 40-43% would make an LPA, without any
acknowledgement that the only legal way to do the former is to do the latter – that is what an LPA
is, and without it, any view as to who should make decisions for you has no effect - it is still (for
medical decisions) the treating physician. There is similarly nothing to suggest that the people who
wished to refuse specific medications understood that the way you do that is through an ADRT (the
1
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 medical decisions) the treating physician. There is similarly nothing to suggest that the people who
wished to refuse specific medications understood that the way you do that is through an ADRT (the
numbers are similar for each - if they were the same people, that should be explained, but I would
be surprised). I suspect what is going on here is that the respondents have limited and sometimes
incorrect knowledge of the legal provisions. That is fair enough – normal people do not sleep with
copies of the MCA under their pillows, and cannot readily parrot out its terms – but if in fact they do
not really understand the provisions, and may misunderstand them in different ways, it raises
 questions as to how we interpret their responses. 
We attempted to prevent this by providing succinct definitions of each of the provisions for ADM
currently available under the MCA at the beginning of the questionnaire (p2, supplementary
material). This was presented on its own page on the online version which we hoped would
encourage people to read these definitions. 
 
Nonetheless, survey methodology is certainly vulnerable to validity problems due to
misunderstanding of questions. We had previously made reference to this in the limitations section,
but we have made this more explicit as follows: 
 
“What’s more it is possible that some participants misunderstood some of the complex concepts
.”contained within the questionnaire
 
However, it is important to note that misunderstanding is not the only possible explanation for
these inconsistencies. In terms of the specific examples given, although an LPA may be the only 
way to designate a substitute decision maker, we should not assume that all service-userslegal
should want to operate on a legal level in this way. The same can be said of ADRTs. This is
supported by the fact that 71% of people indicated a preference for informal ADs which suggests
that a large proportion are actively seeking non-legal routes (although we accept the issues you
raise with this definition and discuss these below). This is further supported by unpublished
findings from focus groups that we have conducted which suggest that ambiguous attitudes
towards legally-binding ADM is a real finding, not just an artefact of our survey design.
 
We discuss this ambiguity in the section “ We haveInconsistent attitudes towards legal status”.  
expanded this section as follows to include the two further examples that you have suggested:
 
“Respondents expressed a preference for of ADM non-legally binding forms which included
over legally binding formsinformation about refusing medication or substitute decision makers that
ADRTs .”could communicate the sameinformation such as and LPAs
 
Unfortunately the number of people wishing to refuse specific medication (68%) was significantly
higher than those who wanted to make an ADRT (35%) and so the additional analysis suggested
was not informative.
 
3. The paper similarly speaks of ‘informal’ plans, as distinct (it would seem) from ADRTs and
statements of wishes. It is not at all clear what this means. It is possible that some respondents
read it as a distinction between oral and written statements, since the questionnaire refers to
ADRTs and statements of wishes as ‘legal documents’. In this the questionnaire is deficient, since
there is no requirement under the MCA that statements of wishes nor (with exceptions not relevant
here) that ADRTs be in any particular form: in both cases quite informal statements, including oral
statements, are meant to have legal effect. (I think there is a sensible argument to the effect that
the MCA should not have taken that approach, but that is an issue for another time: that is the
approach it takes.) At other times, though, the questionnaire seems to view advance care plans or
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 approach it takes.) At other times, though, the questionnaire seems to view advance care plans or
crisis plans (presumably whether oral or in writing?) as ‘informal’, in juxtaposition to ADRTs and
statements of wishes. Again, it is not at all clear what distinction is being drawn here, as wishes or
treatment refusals contained in care plans or crisis plans are manifestly statements of wishes or
ADRTs under the MCA. This lack of clarity again makes analysis of the results difficult: what did the
 people think they were agreeing to?
The purpose of differentiating formal from informal in this way was to distinguish between people
who had engaged or wanted to engage  with the MCA and its associated legal frameworkknowingly
from people who had engaged in ADM outside this legal framework. 
 
ADM is a complex area where the law interacts with medical practice, ethics and, ultimately,
challenging and distressing moments in people’s lives. Although we agree that any form of ADM
has the potential to be interpreted according to the MCA, we were aware that, for some people,
this was not necessarily something they had considered when drafting their advance plan and,
similarly, may not be something they would like to consider as part of their plan. The reasoning
behind this was based on Morriss et al.’s survey which only addressed the MCA provisions for
ADM. As our focus was on a broad definition of ADM, not limited to MCA.
 
Nonetheless, we agree that this distinction was not made clear in the write-up and we can
understand why this may have been confusing. We have therefore added the following to the
introduction:
“If ADM is to be expanded amongst the BP community, it is important to refine our understanding of
the views of those with BP and how existing provision might be tailored to meet the needs of those
using it. In particular, it is possible that people with BP may be practicing ADM without awareness
of the MCA. In order to make this distinction, we have referred to “informal ADM” to mean advance
.”plans that were created outside of the MCA framework for advance planning
In the process of doing this we accept that our definitions at the beginning of the questionnaire are
simplified and do not capture the nuances of the MCA. In particular, we agree that ADRTs and
ASWFs could have been communicated verbally. This is clearly one of the important limitations to
survey methodology when tackling such a complicated and nuanced topic: simplifications are hard
to avoid. We hope that our focus-group work and analysis of the free text boxes will help to
triangulate these findings. We have discussed this in the limitations as follows:
 
“What’s more it is possible that some participants misunderstood some of the complex concepts
Further structured qualitative analysis of the free text boxescontained within the questionnaire….
included in the survey will be reported in a future publication to help deepen our understanding of
the respondents’ views.” 
 
4. Page 4 of the draft contains an explanation of what is meant by ‘self-binding directive’, a concept
that is discussed at some length in the paper. There is a difficulty that the detail of this definition is
not reflected in the only question about SBDs in the questionnaire, which refers only to ‘the person
want[ing] the contents of their advance care plan to be respected even if they no longer agree with
it when they are unwell.’  Again, I am not sure that one can slide between the two articulations in
 quite the way that the paper does.
We agree that the questionnaire item relating to SBDs is a simplified version of the discussion of
SBDs as given in the introduction. Nonetheless we feel this does tackle the central concept at the
heart of self binding:the concept that the individual wants the contents of their plan to be respected
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 heart of self binding:the concept that the individual wants the contents of their plan to be respected
. We were wary of providing a lengthiereven if they no longer agree to it when they are unwell
ethical or legal definition given the nature of surveys. This was discussed during the piloting phase
and our pilots agreed with this decision. 
 
Nonetheless, we accept that it may be misleading to use the same term for both the discussion of
SBDs given in the introduction and the item which we use in the survey. As this is an issue of how
the information from the questionnaire is represented in the paper rather than incoherencies within
the questionnaire itself, we feel this can be remedied. In order to make the distinction we have
added the following to the introduction:
 
“However, at the heart of both accountsis a willingness to engage with the idea of “self-binding” –
the concept that the individual wants the contents of their plan to be respected even if they no
.”longer agree to it when they are unwell
 
We have subsequently referred to “self-binding” rather than SBDs in the results and discussion
whenever referring to this specific item. 
 
Despite this, the outcome of interest relating to SBDs combines this item with an item about
willingness to collaborate with a doctor. We think this is justified as these are, according to Gergel
and Owen’s model, the two essential components of SBD. We have made this more explicit in the
methods by adding the following:
 
“This was designed as a proxy measure for interest in self binding directives as these are essential
Owen components to the model as proposed by Gergel and .”
 
We have also added the following paragraph in the limitations:
 
“We utilised a proxy-measure for interest in SBDs by combining interest in self-binding statements
with a willingness to collaborate with doctors. This was because we decided that attempting to
explain SBDs in a survey was likely to generate confusion. This means our results cannot be
interpreted as a direct endorsement for SBDs. We have conducted focus groups in which SBDs
.”were discussed as part of a parallel study which will help to triangulate these findings
 
 
 5. There is an ambiguity running throughout the questionnaire as to whether it is about treatment
for mental health conditions or advance decision-making much more broadly. The questionnaire
tends to phrase advance decision-making in the context of involvement by the care team and
medical professionals, suggesting the former, while there are references in addition to much
broader planning, albeit often placed in the context of a care plan (which is generally understood
as a relatively medical mechanism). These distinctions are not always teased out as carefully as
they might have been. Thus one might well imagine an affected person P wanting to discuss his or
her medical treatment choices with medical and care professionals; it is much less obvious that he
or she would, if running a business, want to discuss with medical and care professionals how the
business should be run in the event of incapacity. The paper does seem to elide these differences
at times, and I am afraid I did not find this convincing, and when respondents are discussing who
 they would seek advice from, it is not obvious which sort of decision they had in mind.
As you rightly point out, our questionnaire has an implicit focus on mental health treatment and
there are whole domains of advance planning relating to financial affairs, work and relationships
that we have not fully addressed. For our reader’s sake, we have made this more explicit by
2
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 that we have not fully addressed. For our reader’s sake, we have made this more explicit by
including the following to the introduction:
 
“It can also contain information about various aspects of an individual’s life such as medical
treatment, financial affairs or arrangements for work. This study focuses primarily on medical
.”treatment
 
And adding the following to the Aims:
 
“This study aimed to address the following objectives, :”with a focus on medical treatment
 
This does not, however, address the ambiguity within the questionnaire itself. We have therefore
made reference to this in the limitations section, as well as the fact that we do not explore other
forms of ADM as follows:
 
“ the complex concepts What’s more it is possible that some participants misunderstood some of
contained within the questionnaire. Our focus on ADM in relation to medical treatment may have
.added to this potential misunderstanding ADM can relate to financial or work matters and it is
possible that some of our respondents may have been referring to these in some of their
. Further structured qualitative analysis of the free text boxes included in the survey willresponses
be reported in a future publication, helping to disambiguate this.While further research is needed to
.”explore ADM for matters such as finances and work
 
 6. These issues I think really are problematic, and it is difficult to see how they can be remedied
since they flow from the questionnaire itself. The ambiguities do make it somewhat difficult to see
. how the analysis of the results should be understood, however
We hope we have addressed these concerns by drawing attention to the broader issue of
misunderstanding between participants and researchers in the limitations section, clarifying our
definitions of “informal ADM” and the self-binding item and making our medical focus more explicit.
We are therefore confident that our findings remain sufficiently valid for us to draw important, if
tentative, conclusions, despite these limitations. 
7. In the discussion of the MCA and MHA, it would be worth noting that the MHA covers only
treatment for mental disorder: If a person with bipolar has a somatic health disorder, the MCA
 applies.
Thanks for picking up on this. We do state that the MHA“enables compulsory treatment for mental
However to make this more explicit we have added the following:disorder” (p3). 
 
“Although if they were to be treated for a physical health condition, the MCA would still apply.”
 
8. The discussion of ADs and their use in crisis situations is interesting but begs the question of the
50% of respondents who did not feel that their plan was respected in the crisis, the 40% that did
not think they recovered faster, the 40% that did not report improved experience of health services,
the 45% that were not happy with how their plan had been used in the crisis, the 56% that did not
find that the plans were very or extremely helpful in reducing harm to relationships, the 66% that
did not report a reduction in physical harm, and the 77% that did not find them very or extremely
 helpful in reducing overspending. It does feel rather that we are being told half a story here!
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 This was in fact a discussion we had during the drafting of the paper and we decided it was a good
example of the “glass half full vs glass half empty” debate! The point we are trying to make here is
that even the fact that, for example, 50% of ADMs were highly or completely respected, this is a
notable finding given the scepticism around the implementation of ADM in clinical practice. This is
therefore worth stressing. Nonetheless, we agree that this could be misleading and so we have
added the following:
 
“This is preliminary evidence that ADM produced outside of an “experimental” setting canbe used
in crisis with therapeutic effect and that they tend to be respected when they are used, although it
is worth noting that significant proportions of our sample did not report these positive experiences.”
 
In addition, there is in fact a lot less than half of the story being told here as there is only so much
we can understand by these quantitative survey responses. We hope to reveal much more of the
detail underlying these responses during the analysis of the free text boxes.  
 
 9. The fact that after the statistical beeps and whistles get applied, the only correlation with
support of SBDs is shown to be trust in medics is in a sense profoundly unsurprising – although still
worth saying. It does return to the question of what is meant by an SBD, and medical
contextualisation. Do we know whether they were thinking of medical SBDs here (as would be my
 guess) as distinct from SBDs, say, as to how a business will be run?
Although this finding may seem obvious, the debate over the role of medical practitioners in the
production of ADM documents is ongoing (as can be seen in Prof Pathare’s report below). This
finding may, therefore, be more surprising to people who would advocate a patient driven SBD
motivated, for example, by distrust that doctors deliver continuity of care based on prior knowledge
of them.
 
The fact that trust in medics  significantly associated with interest in SBDs would suggest that awas
sufficient number of respondents understood that we were talking about medical SBDs and we
think the effect of any ambiguity in the questionnaire would be to underestimate the strength of this
association. 
 
10. Finally, I think that for a paper of this size, there is too much of a deluge of acronyms – BP, SMI,
DMC-T, ADM, ADRT, EPA, UNCRPD (used only once in the body of the text), MHA, MCA, AS,
SBD, BPUK. Are they all really necessary? Only about half will be known to people who work in the
field; even for them the paper will therefore be hard going. For neophytes, this is likely to be a
 serious barrier.
On re-reading the paper after some time away, I couldn’t agree more with you on this point! As
Professor Pathare suggested, we have therefore added a glossary of terms to make this a little less
daunting. We have also removed the following acronyms: SMI, DMC-T, DMC, UNCRPD and AS.
 I am the first author of this paper. No other competing interests to disclose.Competing Interests:
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 Nick Craddock
Institute of Psychological Medicine & Clinical Neurosciences, Cardiff University, Cardiff, UK
This paper describes a self-report questionnaire study about experiences of, and attitudes towards,
advance decision making (ADM) in individuals with bipolar disorder. The sampling frame population is the
Bipolar UK charity mailing list. The response rate is quoted as 5.61% of those on that list but the main
analyses presented relate to self-reported patients and excludes self-reported carers - a total of 932
respondents out of 20,134 people who had registered their email addresses to be contacted by the
charity.
The authors report various summary statistics that demonstrate that many in their sample has an interest
in ADM and that their access to experience of ADM falls short of their ideal wish. The authors state that
this is the largest study to date of this issue and is a "leap forward" in understanding.
The use of ADM in bipolar disorder is an issue that has complicated ethical and practical issues that
require attention and it is helpful to have research that helps to inform these discussions.  However, there
are substantial limitations with the current study that greatly reduce the ability to make any generalisations
or broad conclusions.
The fundamental limitation is the difficulty in knowing to what extent the sample studied relates to the
population of individuals with a bipolar disorder in the UK. Their respondents are a very small proportion
of those on the email contact list of the charity bipolar UK who have self identified as having a bipolar
diagnosis (who are in turn a subset of the broader membership of bipolar UK) - it would be helpful to
know how the demographics of those on the email list as a whole compare with those in sample studied.
Those who chose to volunteer for the questionnaire study are likely to be substantially biased towards
those who have particular views they would like to articulate - and, of course, the authors acknowledge
the high level of university-level education. 
Of course, the study shows that there are individuals who want to use ADM and that people
have experiences of ADM that are inadequate or unavailable. However, it is not straightforward, with the
data and and analyses presented to know how this may generalise to the wider population of those with
bipolar disorder diagnoses within the UK.
The claim that this is a "leap forward" seems inappropriately hyperbolic. This is a useful first step to
looking at the issue. However, wording such as "suggests the need for more systematic study" would be
much more academically circumspect, together with a more detailed discussion about the difficulties in
generalising. It would be helpful if the authors could indicate what they would consider a study design that
would provide more systematic and generalisable data that would give robust conclusions.
In summary - an interesting preliminary study of an important topic but substantial caution is required in
generalising from findings because of the low response rate and the sample biases.
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Thank you for your thoughtful comments. Please see below for responses to the issues raised in
your report:
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1.The fundamental limitation is the difficulty in knowing to what extent the sample studied relates to
the population of individuals with a bipolar disorder in the UK. Their respondents are a very
small proportion of those on the email contact list of the charity bipolar UK who have self identified
as having a bipolar diagnosis (who are in turn a subset of the broader membership of bipolar UK) -
it would be helpful to know how the demographics of those on the email list as a whole compare
with those in sample studied.
 
We agree that this is an important limitation to our study. In the limitations section we do note this
ourselves: 
“The use of BPUK mailing list as the sampling frame and a low response rate introduce further
selection bias. People with a prior awareness or interest in ADM are likely to be over-represented.
These findings must therefore be generalised with caution and the study seen as exploratory.”
However we accept that it would be helpful to also include it in the concluding paragraph. We have
therefore added the following sentence to the conclusions:
“The results suggest services users with BP want to use ADM and they want collaborative input
from mental health services in doing so. However, the low response rate mean further  research is
”needed to determine the generalisability of these findings.
We also agree that comparing responders to non-responders would allow us to assess how
representative our sample is of the demographics of the BPUK mailing list (although this would still
not address the issue of selection bias towards people with a prior interest in ADM). Unfortunately,
BPUK do not keep this kind of demographic information about the members of their mailing list and
so this was not possible. 
 
2.Of course, the study shows that there are individuals who want to use ADM and that people
have experiences of ADM that are inadequate or unavailable. However, it is not straightforward,
with the data and and analyses presented to know how this may generalise to the wider population
of those with bipolar disorder diagnoses within the UK.
 
We accept that given the methodology used and the response rate achieved, it is very difficult to
comment on the generalisability of these findings. In the limitations section we currently say:
 
“These findings must therefore be generalised with caution and the study seen as exploratory.”
 
To make this limitation more explicit we have edited this sentence as follows:
 
“It is therefore difficult to generalise these findings and the study should be seen as exploratory.”
 
Nonetheless, as we note in the limitations section, the results of this survey do still represent the
opinions and experiences of almost 1000 people with bipolar in the UK. Although these findings
may not be generalisable to the entire population, they are likely to represent a subset of this
population. Given the dearth of research on this topic within this population, particularly with
regards to  of ADM, we feel our findings do still represent an important step forward inexperiences 
the field’s understanding.
 
3.The claim that this is a "leap forward" seems inappropriately hyperbolic. This is a useful first step
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 3.The claim that this is a "leap forward" seems inappropriately hyperbolic. This is a useful first step
to looking at the issue. However, wording such as "suggests the need for more systematic study"
would be much more academically circumspect, together with a more detailed discussion about
the difficulties in generalising. It would be helpful if the authors could indicate what they would
consider a study design that would provide more systematic and generalisable data that would
give robust conclusions.
 
We agree that, given the limitations, it would be preferable to change the language used here. We
have therefore changed this sentence to read:
 
“It provides an in understanding experiences and attitudes towards ADM inimportant step forward 
this group.”
 
With regard to the discussion of generalisation and study design we have already mentioned
respondent-driven sampling which can be utilised in hard to reach groups and given a reference
(reference 36). In addition to the changes already discussed above, we have also indicated a study
design that could help provide more generalisable findings in clinical settings, as suggested:
 
“While in order to understand the generalisability of these findings, a simplified version of the
survey should be conducted using a more representative sampling technique such as convenience
sampling through outpatient clinics or systematic sampling through the use of a patient research
”database such as the Clinical Record Interactive Search system
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